Corrigendum to "Transfusion rate and risk factors in hemiarthroplasty of hip: A nationwide cohort study" [Transfus. Clin. Biol. 2026;33(3):179-186]

  • Park, Ki-Tae; 
  • Park, Jung-Wee; 
  • Lee, Dong-Hoon; 
  • Park, Soon Young; 
  • Han, Min-Ji; 
  • 외 1명
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0

초록

The authors regret that, in the published version of this article, the numerical values for several comorbidity variables in Table 1 and Table 3 were inadvertently assigned to incorrect comorbidity labels. Accordingly, the values in Table 1 and Table 3 have been corrected so that each comorbidity label corresponds to the appropriate patient numbers, percentages, odds ratios, confidence intervals, and P-values. In addition, the corresponding description of comorbidity-related risk factors in the Results section and the risk-factor list for the current study in Table 4 have also been revised for consistency. This correction affects the presentation of comorbidity-related values in Table 1 and Table 3 and the related text only. The overall study population, transfusion rate, transfusion volume, statistical methods, main findings, interpretation, and conclusions of the article remain unchanged. The authors would like to apologise for any inconvenience caused. 3.5 Risk factors of transfusion in HA Among medical comorbidities, preoperative anemia (aOR = 2.69, 95% CI: 2.61–2.77; P < 0.001), acute myocardial infarction (aOR = 1.16, 95% CI 1.06–1.27; P = 0.001), congestive heart failure (aOR = 1.16, 95% CI 1.12–1.20; P < 0.001), cerebrovascular disease (aOR = 1.10, 95% CI 1.07–1.13; P < 0.001), dementia (aOR = 1.13, 95% CI 1.09–1.16; P < 0.001), diabetes with complications (aOR = 1.21, 95% CI 1.16–1.25; P < 0.001), renal disease (aOR = 1.48, 95% CI 1.36–1.61; P < 0.001), cancer (aOR = 1.17, 95% CI 1.12–1.23; P < 0.001), and moderate or severe liver disease (aOR = 1.60, 95% CI 1.27–2.02; P = 0.013) were significantly associated with increased risk of transfusion. Corrected table 1 Demographic data of the patients who underwent hemiarthroplasty according to transfusion status. [Table presented]aThis value indicates mean and standard deviation. Corrected table 3. The risk factor of transfusion in the patients undergoing hemiarthroplasty. [Table presented] Corrected table 4. Transfusion rate and risk factors for transfusion in registry studies. [Table presented]

제목
Corrigendum to "Transfusion rate and risk factors in hemiarthroplasty of hip: A nationwide cohort study" [Transfus. Clin. Biol. 2026;33(3):179-186]
저자
Park, Ki-Tae; Park, Jung-Wee; Lee, Dong-Hoon; Park, Soon Young; Han, Min-Ji; Lee, Young-Kyun
DOI
10.1016/j.tracli.2026.07.009
발행일
2026-11
유형
Correction
저널명
Transfusion Clinique et Biologique
권
33
호
4
페이지
304 ~ 306